Alkendi, A. Et Al. 2022. The Evaluation of Multidrug Resistance-Related Protein 1 as a Prognostic Factor in the Pediatric B-cell Acute Lymphoblastic Leukemia: A Pilot Study. Bezmiâlem Science , vol.10, no.6 , 691-697.

Alkendi, A., Gelmez, M. Y., Tahralı, İ., Aydoğan, G., Deniz, G., & Çınar, S., (2022). The Evaluation of Multidrug Resistance-Related Protein 1 as a Prognostic Factor in the Pediatric B-cell Acute Lymphoblastic Leukemia: A Pilot Study. Bezmiâlem Science , vol.10, no.6, 691-697.

Alkendi, Amani Et Al. "The Evaluation of Multidrug Resistance-Related Protein 1 as a Prognostic Factor in the Pediatric B-cell Acute Lymphoblastic Leukemia: A Pilot Study," Bezmiâlem Science , vol.10, no.6, 691-697, 2022

Alkendi, Amani Et Al. "The Evaluation of Multidrug Resistance-Related Protein 1 as a Prognostic Factor in the Pediatric B-cell Acute Lymphoblastic Leukemia: A Pilot Study." Bezmiâlem Science , vol.10, no.6, pp.691-697, 2022

Alkendi, A. Et Al. (2022) . "The Evaluation of Multidrug Resistance-Related Protein 1 as a Prognostic Factor in the Pediatric B-cell Acute Lymphoblastic Leukemia: A Pilot Study." Bezmiâlem Science , vol.10, no.6, pp.691-697.

@article{article, author={Amani Alkendi Et Al. }, title={The Evaluation of Multidrug Resistance-Related Protein 1 as a Prognostic Factor in the Pediatric B-cell Acute Lymphoblastic Leukemia: A Pilot Study}, journal={Bezmiâlem Science}, year=2022, pages={691-697} }